Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AU-011 |
Trade Name | |
Synonyms | Bel-sar|Belzupacap Sarotalocan |
Drug Descriptions |
AU-011 is a photodynamic therapy comprised of human papilloma virus derived nanoparticles conjugated to infrared dye, IR700, which upon irradiation results in reactive oxygen species generation and thus, subsequent cell death (Cancer Res 2014;74(19 Suppl):Abstract nr 1770, PMID: 30844944). |
DrugClasses | |
CAS Registry Number | 2390462-37-8 |
NCIT ID | C137951 |